Bryan et al. found FGFR2 was underexpressed in breast tumours compared with normal breast tissue [58], while Cox et al. found an association between ER and FGFR2 in HER2-negative tumours, but the association was far weaker in HER2-positive tumours [59]. The gene discussed is ERBB2; the disease is neoplasm.